To view this email as a web page, click here.
 
FDA advisors recommend 2 opioid use disorder drugs
Two opioid use disorder drugs have been recommended for approval by FDA committees.
Read more
 
A review of peripherally acting mu-opioid receptor antagonists
A review on peripherally acting mu-opioid receptor antagonists and insight on formulary considerations when evaluating these agents.
Find out more
 
Top 6 new facts on drug overdoses
Deaths from drug overdoses are the leading cause of injury death in the United States, ahead of deaths linked to motor vehicles and firearms, according to a National Drug Threat Assessment (NDTA), released by the Drug Enforcement Administration.
Read more
 
FDA to drug maker: Pull opioid pain drug
Potential public health consequences prompts FDA to request removal of opioid pain medication.
Read more
 
FDA clears first opioid withdrawal device
FDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.